Alkylating DNA damage stimulates a regulated form of necrotic cell death

被引:502
作者
Zong, WX
Ditsworth, D
Bauer, DE
Wang, ZQ
Thompson, CB [1 ]
机构
[1] Univ Penn, Dept Canc Biol, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA
[2] Int Agcy Res Canc, Unit Gene Environm Interact, F-69008 Lyon, France
关键词
alkylating DNA damage; necrosis; PARP; metabolism; Bax; Bak; p53;
D O I
10.1101/gad.1199904
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Necrosis has been considered a passive form of cell death in which the cell dies as a result of a bioenergetic catastrophe imposed by external conditions. However, in response to alkylating DNA damage, cells undergo necrosis as a self-determined cell fate. This form of death does not require the central apoptotic mediators p53, Bax/Bak, or caspases and actively induces an inflammatory response. Necrosis in response to DNA damage requires activation of the DNA repair protein poly(ADP-ribose) polymerase (PARP), but PARP activation is not sufficient to determine cell fate. Cell death is determined by the effect of PARP-mediated p-nicotinamide adenine dinucleotide (NAD) consumption on cellular metabolism. Cells using aerobic glycolysis to support their bioenergetics undergo rapid ATP depletion and death in response to PARP activation. In contrast, cells catabolizing nonglucose substrates to maintain oxidative phosphorylation are resistant to ATP depletion and death in response to PARP activation. Because most cancer cells maintain their ATP production through aerobic glycolysis, these data may explain the molecular basis by which DNA-damaging agents can selectively induce tumor cell death independent of p53 or Bcl-2 family proteins.
引用
收藏
页码:1272 / 1282
页数:11
相关论文
共 47 条
  • [1] Ways of dying: multiple pathways to apoptosis
    Adams, JM
    [J]. GENES & DEVELOPMENT, 2003, 17 (20) : 2481 - 2495
  • [2] DEVIANT ENERGETIC METABOLISM OF GLYCOLYTIC CANCER-CELLS
    BAGGETTO, LG
    [J]. BIOCHIMIE, 1992, 74 (11) : 959 - 974
  • [3] Mice lacking the poly(ADP-ribose) polymerase gene are resistant to pancreatic beta-cell destruction and diabetes development induced by streptozocin
    Burkart, V
    Wang, ZQ
    Radons, J
    Heller, B
    Herceg, Z
    Stingl, L
    Wagner, EF
    Kolb, H
    [J]. NATURE MEDICINE, 1999, 5 (03) : 314 - 319
  • [4] BUTLER AP, 1985, J BIOL CHEM, V260, P613
  • [5] CHABRUER BA, 2001, CANC CHEMOTHERAPY BI
  • [6] BCL-2, BCL-XL sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis
    Cheng, EHYA
    Wei, MC
    Weiler, S
    Flavell, RA
    Mak, TW
    Lindsten, T
    Korsmeyer, SJ
    [J]. MOLECULAR CELL, 2001, 8 (03) : 705 - 711
  • [7] Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions
    D'Amours, D
    Desnoyers, S
    D'Silva, I
    Poirier, GG
    [J]. BIOCHEMICAL JOURNAL, 1999, 342 : 249 - 268
  • [8] BAX and BAK mediate p53-independent suppression of tumorigenesis
    Degenhardt, K
    Chen, GH
    Lindsten, T
    White, E
    [J]. CANCER CELL, 2002, 2 (03) : 193 - 203
  • [9] Bax and Bak independently promote cytochrome c release from mitochondria
    Degenhardt, K
    Sundararajan, R
    Lindsten, T
    Thompson, C
    White, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (16) : 14127 - 14134
  • [10] Devita Vincent T. Jr., 1997, P333